Abnormal stability of wild-type p53 protein in a human lung carcinoma cell line

Biochemical and Biophysical Research Communications

Volumn 330, Issue 2, 2005, Pages 483-488

  Yamauchi, Motohiro ^a   Suzuki, Keiji ^a   Kodama, Seiji ^a,b   Watanabe, Masami ^a,c  

^a NAGASAKI UNIVERSITY   (Japan)

^b Osaka Prefecture University   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME; PROTEASOME INHIBITOR; PROTEIN MDM2; PROTEIN P53;

ARTICLE; CANCER CELL; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; UBIQUITINATION; WILD TYPE;

EID: 15744406023     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.11.174     Document Type: Article

References (33)

1. M. Ashcroft, and K.H. Vousden Regulation of p53 stability Oncogene 18 1999 7637 7643 (Review)
2. N.D. Lakin, and S.P. Jackson Regulation of p53 in response to DNA damage Oncogene 18 1999 7644 7655 (Review)
3. G.M. Wahl, and A.M. Carr The evolution of diverse biological responses to DNA damage: insights from yeast and p53 Nat. Cell Biol. 3 2001 E277 E286 (Review)
4. Y. Haupt, R. Maya, A. Kazaz, and M. Oren Mdm2 promotes the rapid degradation of p53 Nature 387 1997 296 299
5. M.H.G. Kubbutat, S.N. Jones, and K.H. Vousden Regulation of p53 stability by MDM2 Nature 387 1997 299 303
6. S. Fakharzadeh, R.S. Trusko, and D. George Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line EMBO J. 10 1991 1565 1569
7. J.D. Oliner, K.W. Kinzler, P.S. Meltzer, D.L. George, and B. Vogelstein Amplification of a gene encoding a p53-associated protein in human sarcomas Nature 358 1992 80 83
8. J. Momand, D. Jung, S. Wilczynski, and J. Niland The MDM2 gene amplification database Nucleic Acid Res. 26 1998 3453 3459
9. C.G. Maki, J.M. Huibregtse, and P.M. Howley In vivo ubiquitination and proteasome-mediated degradation of p53 Cancer Res. 56 1996 2649 2654
10. R. Honda, H. Tanaka, and H. Yasuda Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 FEBS Lett. 420 1997 25 27
11. Y. Barak, T. Juven, R. Haffner, and M. Oren mdm2 expression is induced by wild-type p53 activity EMBO J. 12 1993 461 468
12. R.L. Bar-Or, R. Maya, L.A. Segel, U. Alon, A.J. Levine, and M. Oren Generation of oscillation by the p53-Mdm2 feedback loop: a theoretical and experimental study Proc. Natl. Acad. Sci. USA 97 2000 11250 11255
13. P.H. Kussie, S. Gorina, V. Marechal, B. Elenbaas, J. Moreau, A.J. Levine, and N.P. Pavletich Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain Science 274 1996 948 953
14. S.-Y. Shieh, M. Ikeda, Y. Taya, and C. Prives DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 Cell 91 1997 325 334
15. N.H. Chehab, A. Malikzay, E.S. Starvridi, and T.D. Halazonetis Phosphorylation of Ser20 mediates stabilization of human p53 in response to DNA damage Proc. Natl. Acad. Sci. USA 96 1999 13777 13782
16. N.H. Chehab, A. Malikzay, M. Appel, and T.D. Halazonetis Chk2/hCds1 functions as a DNA damage checkpoint in G1 by stabilizing p53 Genes Dev. 14 2000 278 288
17. K. Savitsky, A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D.A. Tagle, S. Smith, T. Uziel, S. Sfez, M. Ashkenazi, I. Pecker, M. Frydman, R. Harnik, S.R. Patanjali, A. Simmons, G.A. Clines, A. Sartiel, R.A. Gatti, L. Chessa, O. Sanal, M.F. Lavin, N.G.J. Jaspers, A.M.R. Taylor, C.F. Arlett, T. Miki, S.M. Weissman, M. Lovett, F.S. Collins, and Y. Shiloh A single ataxia telangiectasia gene with a product similar to PI-3 kinase Science 268 1995 1749 1753
18. S. Banin, L. Moyal, S.-Y. Shieh, Y. Taya, C.W. Anderson, L. Chessa, N.I. Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv Enhanced phosphorylation of p53 by ATM in response to DNA damage Science 281 1998 1674 1677
19. C.E. Canman, D.-S. Lim, K.A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M.B. Kastan, and J.D. Siliciano Activation of the ATM kinase by ionizing radiation and phosphorylation of p53 Science 281 1998 1677 1679
20. A. Hirao, Y.-Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, H. Yoshida, D. Liu, S.J. Elledge, and T.W. Mak DNA damage-induced activation of p53 by the checkpoint kinase Chk2 Science 287 2000 1824 1827
21. R. Melchionna, X.-B. Chen, A. Blasina, and C.H. McGowan Nat. Cell Biol. 2 2000 762 765
22. C.G. Maki, and P.M. Howley Mol. Cell. Biol. 17 1997 355 363
23. M. Watanabe, M. Suzuki, K. Suzuki, K. Nakano, and K. Watanabe Effect of multiple irradiation with low doses of gamma-rays on morphological transformation and growth ability of human embryo cells in vitro Int. J. Radiat. Biol. 62 1992 711 718
24. K. Suzuki, I. Mori, Y. Nakayama, M. Miyakoda, S. Kodama, and M. Watanabe Radiat. Res. 155 2001 248 253
25. D.A. Freedman, and A.J. Levine Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6 Mol. Cell. Biol. 18 1998 7288 7293
26. J. Roth, M. Dobbelstein, D.A. Freedman, T. Shenk, and A.J. Levine Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein EMBO J. 17 1998 554 564
27. W. Tao, and A.J. Levine Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53 Proc. Natl. Acad. Sci. USA 96 1999 3077 3080
28. T.R. Shirangi, A. Zaika, and U.M. Moll Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage FASEB J. 16 2002 420 422
29. T.W. Joseph, A. Zaika, and U.M. Moll Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage FASEB J. 17 2003 1622 1630
30. S. Glockzin, F.-X. Ogi, A. Hengstermann, M. Scheffner, and C. Blattner Involvement of the DNA repair protein hHR23 in p53 degradation Mol. Cell. Biol. 23 2003 8960 8969
31. T. van Laar, A.J. vander Eb, and C. Terleth A role for Rad23 proteins in 26S proteasome-dependent protein degradation? Mutat. Res. 499 2002 53 61 (Review)
32. H. Rao, and A. Sastry Recognition of specific ubiquitin conjugates is important for the proteolytic functions of the ubiquitin-associated domain proteins Dsk2 and Rad23 J. Biol. Chem. 277 2002 11691 11695
33. I.A. McNeish, S.J. Bell, and N.R. Lemoine Gene therapy progress and prospects: cancer gene therapy using tumor suppressor genes Gene Ther. 11 2004 497 503